Skip to main content
Clinical Trials/JPRN-UMIN000005306
JPRN-UMIN000005306
Completed
Phase 2

The efficacy and the safety of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced pancreatic cancer with carcinomatous ascites. - A feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced pancreatic cancer with carcinomatous ascites.

The University of Tokyo0 sites30 target enrollmentApril 1, 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Advanced pancreatic cancer with carcinomatous ascites.
Sponsor
The University of Tokyo
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with synchronous or metachronous concomitant malignancies 2\) Patients with uncontrolled diabetes mellitus 3\) Patients with uncontrolled hypertension 4\) Patients with renal failure undergoing hemodialysis 5\) Patients with prior myocardial infarction or unstable angina within 6 months 6\) Patients with liver cirrhosis 7\) Patients with intestinal pneumonia, pulmonary fibrosis, and severe pulmonary emphysema 8\) Pregnant or lactating female and patients who is considering pregnancy 9\) Patients with contraindication for S\-1 or paclitaxel 10\) Inappropriate patients for entry on this study in the judgement of the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials